A Timeline to Heparin in COVID-19 Patients
Perspective on how the anticoagulant could progress to human trials and potentially, marketing use for coronavirus prevention.
Symptoms Remain After COVID-19 Treatment
In a small Italian study, a majority of patients who were hospitalized and recovered from the virus, had lingering symptoms and many had a “worsened quality of life.”
FDA Issues More Sanitizer Recalls Over Methanol Content
Weekly, we identify FDA announcements that pertain to infectious disease care. This week, FDA continued an investigation of undeclared wood alcohol contents in hand sanitizer.
Serial Testing Identifies COVID-19 Cases at a Corrections Facility
Asymptomatic and presymptomatic cases of COVID-19 create challenges for identifying and combating the spread of the virus in detention facilities.
Could Heparin Prevent Coronavirus Infection?
A discussion with an RPI investigator after promising early findings.
COVID-19 Pandemic Threatens Global Infectious Disease Control Progress
A modeling study from Imperial College shows the COVID-19 pandemic may have significant effect on mortality among other infectious disease patients.
Improving Influenza Surveillance Systems to Help the Most Vulnerable At-Risk Patients
A model including clinical symptom reports, Internet searches, and emergency room data predict influenza hospitalizations better in affluent vs. poorer communities.
Applying African Ebola Response Experience to the Coronavirus Pandemic
West and Central African nations have been developing infrastructure to combat ebola, malaria, malnutrition, and more.
The Dangers of Respiratory Droplets to Frontline Health Care Providers
A paper examines how these droplets are transmitted and ways to protect these providers from COVID-19.
How Will Coronavirus Impact HIV, TB, & Malaria in Developing African Countries?
A modeling study from Imperial College shows the COVID-19 pandemic may require balancing with other infectious disease priorities.
Understanding Excess Deaths in the Wake of COVID-19
The burden of COVID-19 is far reaching and a new study into excess mortality sheds light on this saddening topic.
Hydroxychloroquine, Chloroquine Prescriptions Spiked as COVID-19 Reached US
Tens of thousands of patients were prescribed the anti-malarial drugs in the early weeks of the pandemic, a statistic that concerns public health officials.
FDA-Approved Anticoagulant May Stop Coronavirus From Binding to Human Cells
Heparin may lower the odds of SARS-CoV-2 infection, according to investigators from the Rensselaer Polytechnic Institute.
Who Should be Wearing Face Masks?
Rajiv Dhand, MD, discusses the importance of everyone wearing face masks including health care workers seeing patients outside the hospital setting.
Can Baloxavir Limit Spread of Flu Cases Within Families?
New study findings shed light on the positive effects of baloxavir for preventing influenza spread in household settings.
Why is Ebola Endemic to the DRC?
In Mbandaka, an 11th outbreak of Ebola is emerging. This outbreak has renewed questions about what makes the virus such a challenge for Congolese society to reign in.
Is Kawasaki Disease Triggered by Underlying Infection Like COVID-19 or Flu?
Following an outbreak of both COVID-19 and H1N1 influenza, Parisian hospital admissions for Kawasaki disease increased.
Skilled Nursing Facilities Face Spikes in Deaths, Drops in Admissions
Skilled nursing facilities are facing an unprecedented crisis as deaths rise amid the COVID-19 pandemic while admissions and patient census decline, a new study shows.
COVID-19 Vaccine Candidate Induces Immune Response in All Phase 1 Participants
The mRNA-1273 vaccine candidate from Moderna will progress to a phase 3 trial in adults later this summer.
Getting Younger People on PrEP
Why it's critical for the future of HIV prevention for programs like the California PrEP-AP to reach younger at-risk persons now.
Complicating the Coronavirus Lockdown Debate
A modeling study from Imperial College shows the pandemic may have significant effect on mortality among other infectious disease patients.
Unmet HIV Therapy Needs, Cure Research, and Virtual Conferences
In the second segment of the interview, Gilead’s Gelezinuas and SenGupta discuss the areas of unmet HIV therapy needs, cure research, and the benefits of a virtual conference.
C. diff. Infection, Renal Impairment Have Lower Risk of Recurrence if Given Bezlotoxumab
A new study finds patients with Clostridium difficile infection are more likely to face a recurrence of the infection if they also have renal impairment. However, bezlotoxumab can reduce that risk.
COVID-19 Could Raise HIV, TB, Malaria Death Rates
The Social Hurdles of HIV Awareness and Prevention
How a sexually-transmitted virus is hindered by limited marketing, and how its stigmas compare to those developing around COVID-19.
FDA Fast Tracks 2 COVID-19 Vaccines
Pfizer and BioNTech were given approval by the federal agency to expedite their work on investigational vaccines.
Insights into Vesatolimod
Gilead provides some important information on this investigational therapy.
WHO Ebola Virus Disease Definitions Are Suboptimal, Study Shows
Ebola virus disease definitions from the World Health Organization definitions could be improved by including contact history and intense fatigue as a key symptom and excluding fever, a new study found.
'Warp Speed,' Without Cutting Corners on Safety
Efforts to develop a COVID-19 vaccine must not skip important steps during clinical evaluation, experts explain.
NSAIDS, Influenza Hospitalization, and Adverse Outcomes
Is there an association with adverse outcomes in patients hospitalized with influenza taking NSAIDS?
